To explore the association between clock circadian regulator circadian locomotor output cycles kaput gene (CLOCK) and the forming of atherosclerotic plaques and its underlying mechanisms, mouse aortic endothelial cells (MAECs) and atherosclerosis (AS) mouse model were recruited for our study. The apoE gene knockout mouse was used as the model of AS and we accelerated the formation of unstable plaques through the combination of carotid artery ligation and high-fat (HF) diet administration (0.2% cholesterol, 20% fat). The mRNA and protein expressions of CLOCK in peripheral blood monouclear cells of acute coronary syndrome (ACS) patients or mouse AS model were detected by qPCR, western blot analysis and immunohistochemical staining. The number of adherent cells and atherosclerotic plaques was counted to assess the effects of CLOCK on the progression of ACS, and adherence-associated genes, such as vascular cell adhesion molecule (VCAM)-1, C-C motif chemokine ligand 2 (CCL-2), and CCL-5. The results showed that CLOCK expression was significantly increased in both ACS patients and AS mouse model. The levels of CLOCK, leukemia inhibitory factor (LIF), intercellular adhesion molecule 1 (ICAM-1), perilipin 2 (ADFP), nuclear factor kappa B (NF-κB), and plasminogen activator inhibitor-1 (PAI-1), as well as the number of atherosclerotic plaques were elevated in the AS mouse model, as compared with the control group. Chromatin immunoprecipitation assay showed that CLOCK bound directly to the promoter of PAI-1 gene and CLOCK could positively regulate the expressions of LIF, ICAM-1, ADFP, NF-κB, and PAI-1. Reduction of CLOCK expression would decrease the expressions of VCAM-1, CCL-2, and CCL-5, and the number of adherent cells and atherosclerotic plaques, but these effects were neutralized when PAI-1 was simultaneously overexpressed in either mouse model or MAECs. Our results demonstrate that CLOCK overexpression triggers the formation of atherosclerotic plaques by directly upregulating PAI-1 expression.
Introduction
Acute coronary syndrome (ACS) represents a series of indications of sudden cardiac ischemia that involve a variety of causes, including acute myocardial infarction and unstable angina [1] , as well as atheromatous plaques [2] . Instability and rupture of atherosclerotic plaques are contributed to the occurrence of cardiovascular disease. Based on this, delving into the molecular mechanism of unstable plaque formation and development is beneficial to find effective methods to stabilize the unstable plaque. Hence, in the present study, we aimed to investigate the formation mechanism of unstable plaque and find strategies to prevent atheromatous plaques from rupture.
Muller, Pell, and D'Alonzo first demonstrated circadian variation of acute myocardial infarction, characterized by a morning peak (06:00-12:00), particularly during the first few hours after awakening [3, 4] . The internal circadian clock was proved to control numerous important physiological functions at different levels, including molecular, cellular, and whole body levels. The expressions of~10% of rodent cardiac genes were shown to exhibit significant diurnal variations [5] . Cardiovascular diseases have been associated with the loss of circadian rhythm [6] , and patients with coronary heart disease and ACS lose diurnal rhythms of endothelial function [7] . All these observations underscore the key role of core circadian genes in the maintenance and modulation of cardiovascular system, dysfunction of which might lead to the initiation or progression of cardiovascular diseases.
Circadian clock is a well-conserved mechanism that permits biologically efficient circadian timing of physiology and behavior. In mammals, except for the master oscillator located in the suprachiasmatic nucleus [8] , autonomous peripheral oscillators have been defined for most tissues, including vasculature, heart, kidney, and peripheral blood monouclear cells (PBMCs) [9] . The core molecular oscillator is composed of interlocking positive and negative transcriptional and translational feedback loops that drive circadian gene expression [10] . Components of the mammalian molecular circadian clock include three Period proteins (Per1, Per2, and Per3), two Cryptochromes (Cry1 and Cry2), and two PAS helix-loop-helix proteins, circadian locomotor output cycles kaput (CLOCK) and aryl hydrocarbon receptor nuclear translocator-like (Bmal 1) [11] . CLOCK and Bmal 1 heterodimerize to form an active transcription complex that leads to increases in Per and Cry. Complexes of Per and Cry proteins translocate to the nucleus to inhibit CLOCK:Bmal 1-mediated transcription. CLOCK and Bmal 1 heterodimers also stimulate the transcription of many other clock-controlled genes which, in turn, influence functions external to the timing mechanism and mediate the output of the clock [12] . Per and Cry proteins sequentially dimerize to repress their own transcription, forming the negative limb of this auto-regulatory feedback loop [13] . A second loop involves the circadian regulation of Bmal 1 transcription by REV-ERBα [14] and RORα [15] . Therefore, such genes were selected to be studied among patients with ST elevation myocardial infarction (STEMI) and healthy volunteers.
The pathological processes of ACS include inflammation, thrombosis and plaque rupture. Miziastec et al. [16] reported that serum concentration of interleukin (IL)-2 was significantly higher in patients with ACS, and the progression from coronary artery disease (CAD) to ACS was triggered/accompanied by prolonged immune activation. Thompson et al. [17] indicated a significant role for transforming growth factor β (TGFβ) in the response of the heart to injury. In the immune system, many functions and parameters have been described to be time-of-day-dependent, such as lymphocyte proliferation [18] , natural killer cell activity [19] , humoral immune response [20] , and cytokine levels [21] . Circadian clock regulates the circadian rhythms in inflammatory innate immune functions, e.g. isolated spleen cells stimulated with bacterial endotoxin at different circadian times display circadian rhythms in tumor necrosis factor α (TNF-α) and IL-6 secretion [22] . In addition, CLOCK was shown to be important for nuclear factor kappa B (NF-κB)-mediated transcription of various proinflammatory cytokines [23] . However, the role of CLOCK in the progression of ACS still remains incompletely understood.
Additionally, reports have also elucidated that the timing of adverse cardiovascular events is coincide with oscillations of the expression of known hemostasis regulators, such as plasminogen activator inhibitor-1 (PAI-1) [24] , a time-dependent risk factor for cardiovascular disease [25] . PAI-1 is a serine proteinase inhibitor and the main physiological inhibitor of the endogenous fibrinolytic system [26] [27] [28] . Circulating PAI-1 concentration has been associated with the incidence of cardiovascular events, such as ACS [29] [30] [31] . Interventions that can reduce cardiovascular events have been shown to reduce PAI-1 concentration [32] . PAI-1 was found to have a potential regulatory function of blood coagulation by exerting anti-coagulant effects through the activation of protein C [33] , which might play an important role in acute myocardial infarction.
In the present study, we reported that the CLOCK gene appears to be a link between circadian rhythm disruption and the formation of atherosclerotic plaque. In addition to investigation of the circadian expression pattern of genes, chromatin immunoprecipitation (CHIP) analysis was utilized to screen the potential target of CLOCK from several molecules. Furthermore, the difference in circadian gene's target expression between ACS patients and healthy volunteers was explored. Data from our study revealed that abnormal oscillation of CLOCK gene might contribute to the circadian variation of cardiovascular events and the formation of atherosclerotic plaques by alternating the expression of PAI-1.
Materials and Methods

Enrolled subjects
In total, 12 healthy male volunteers and 25 male ACS patients with carotid plaque (CP), aged 50-70 years, from the Department of Cardiology, Shanghai Changzheng Hospital (Shanghai, China) between January 1 and December 31, 2011 were enrolled to this study. Healthy volunteers maintained a regular sleep-wake pattern, and received normal hematology and urine analysis. None of them had traveled across time zones or had been on medication in the past 6 months. Participants with any of the following diseases were excluded: (i) hypertension, hyperlipidemia, and diabetes mellitus; (ii) ischemic or hemorrhagic stroke, and a history of arterial thrombosis; (iii) Alzheimer's disease; (iv) history of malignancy; and (v) psychiatric diseases (assessed by the Mini-International Neuropsychiatric Interview). The study was reviewed by the Ethics Committee of Second Military Medical University, and performed in accordance with the ethical standards in the 1964 Declaration of Helsinki. The informed consents were obtained from all enrolled subjects.
Hypercholesterolemic apoE
−/− murine model For cell transfection, pCMV6-CLOCK, siRNA-CLOCK, pCMV6-PAI-1 or siRNA-PAI-1 or their negative control (NC) synthesized by GenePharma (Shanghai, China) were transfected to cells with Lipofectamine 2000 (Invitrogen, Carlsbad, USA) according to the manufacture's description. Sequences for si-CLOCK were: si-1: 5′-CCTCTAGAAGCTCACGAAA-3′; si-2: 5′-GCAACTTCAGATGG TCCAT-3′; si-3: 5′-CCAGGTTCAGAGTGGACAT-3′; si-NC: 5′-CCTAGAAGCTCACGCTAAA-3′. Sequences for si-PAI-1 were: si-1: 5′-GGGTGGAAAGGCATACCAA-3′; si-2: 5′-CCATGATGG CTCAGAGCAA-3′; si-3: 5′-GCTGAACTCATCAGACAAT-3′; si-NC: 5′-CCAGTATCGGACGATGCAA-3′.
Patient protocol
Clinical characteristics, including age, body mass index (BMI), diabetes mellitus, hypertension, smoking, obesity, and levels of cholesterol, triglycerides, low-density lipoprotein cholesterol (LDLc), high-density lipoprotein cholesterol (HDL-c), fasting blood glucose (FBG), and glycosylated hemoglobin (HbA1C) were recorded for both ACS patients and healthy volunteers. Peripheral venous blood was drawn every 4 h starting at 0:00 a.m. the day following hospitalization for a total of six samples. Blood samples were collected into heparinized tubes, placed on ice and centrifuged at 4°C at 3000 g for 7 min. Plasma was stored at −80°C until further analysis. Total RNA from (3-5) × 10 6 leukocytes was isolated using
RNeasy Plus Micro and Mini Kits (Qiagen, New York, USA) according the recommendations of the manufacturer, then precipitated, washed twice with 70% ethanol and resuspended in 25 μl of distilled water. RNA integrity was verified in agarose gel electrophoresis (Thermo Fisher Scientific), followed by ethidium bromide staining of the 28S and 18S ribosomal RNA. Then 500 ng total RNA was reverse transcribed with hexamers (Eurogentec, Liege, Belgium) using MMLV reverse transcriptase (Invitrogen). Expression of the circadian genes including RAR-related orphan receptor α (RORα), RORγ, nuclear receptor subfamily 1, group D, member 1 (REV-ERBα), REV-ERBβ, Bmal 1, Bmal 1α, CLOCK, Cry 1, Cry 2, Per1, Per2, and Per3, the AS associated genes such as leukemia inhibitory factor (LIF), intercellular adhesion molecule 1 (ICAM-1), ADFP, NF-κB, and PAI-1, and the adhesion genes including vascular cell adhesion molecule (VCAM-1), C-C motif chemokine ligand 2 (CCL-2), and CCL-5 in MAECs were assessed using quantitative real-time polymerase chain reaction (qPCR).
qPCR assay
The qPCR was performed with a Light Cycler 1.0 (Roche Applied Science, Shanghai, China) using SYBR green kit (Bio-Rad, Hercules, USA) according to manufacturer's recommendations. The amplification procedure was as follows: 10 min at 95°C, 30 s at 95°C, 10 s at 58°C and 10 s at 72°C for 45 cycles. The primers were listed in Table 1 . Data were analyzed on the basis of the relative expression method with the formula 2
−ΔΔCT
, where ΔΔCT = ΔCT (sample) -ΔCT (calibrator = average CT values of all samples within each Table 1 . Sequences of primers used for qPCR
Gene
Forward sequence (5′→3′) Reverse sequence (5′→3′)
group), and ΔCT is the CT of the housekeeping gene (GAPDH) subtracted from the CT of the target gene. Time-series data were analyzed using the Chronos-fit 1.06 software with 24-h periodicity.
Immunohistochemical analysis
The corresponding sections of fresh artery tissues from the mice were incubated with the anti-CLOCK primary antibodies (1:200; Abcam, Cambridge, USA) and with horseradish peroxidase (HRP)-conjugated IgG secondary antibody (Zhongshan Jinqiao Biotechnology, Beijing, China). In NCs, incubation with the above antibodies was omitted. Finally, the sections were examined using an upright light microscope (Olympus, Tokyo, Japan) and analyzed using ImageJ software (National Institutes of Health, Bethesda, USA). At least three randomly selected areas were evaluated.
CHIP assay
PBMCs were incubated with formaldehyde for 10 min at 37°C and the reaction was stopped by addition of 125 mM glycine. Cells were then washed twice with ice-cold PBS, scraped into MC lysis buffer containing Complete TM protease inhibitor cocktail (Roche, Basel, Switzerland). Nuclei were pelleted by centrifugation at 500 g for 5 min at 4°C, resuspended in MNase buffer and MNase (Thermo Fisher Scientific), and incubated for 10 min 37°C. Lysates were sonicated to shear DNA into fragments of 0.3-1.5 kb in length. To reduce nonspecific background, samples were pre-cleared by incubation with Protein A/G-agarose beads (Santa Cruz Biotechnology, Santa Cruz, USA) for 1-2 h at 4°C, with agitation. . Proteins were detached from the agarose beads by addition of 100 μl elution buffer. Cross-links were reversed by addition of 8 μl of 5 M NaCl to all reactions, including input control, and heating overnight at 65°C. The DNA was ethanol-precipitated, digested with proteinase K, phenol-extracted, and then resuspended in TE before PCR analysis. qPCR parameters were as follows: initial denaturation for 10 min at 94°C, followed by denaturation for 20 s at 94°C, annealing and extension for 1 min at 60°C for 50 cycles.
Western blot analysis
In brief, 3 ml blood sample containing anti-coagulant was mixed with 3 ml PBS, and the mixture was added into 5 ml lymphophoric cell separation liquid (Solarbio, Beijing, China). Then it was centrifuged at 12,000 g for 20 min. Total protein was extracted by Minute™ Protein Extraction Kits (Invent Biotechnologies, Eden Prairie, USA) and protein concentration was detected using BCA Kit (Thermo Fisher Scientific). All samples (20 μl each) were subject to SDS-PAGE and then transferred onto PVDF membrane. The membrane was blocked with 5% skim milk and then incubated with the primary antibodies against CLOCK (Abcam) and GAPDH (Abcam) overnight at 4°C. After extensive wash, membranes were incubated with HRPconjugated secondary antibody (Cell Signaling Technology, Beverly, USA) for 1 h at room temperature. Finally, the blots were visualized using an enhanced chemiluminescence detection kit (Millipore, Billerica, USA) and GeneGnome chemiluminescence imaging system (Syngene, Cambridge, UK) was used to measure the grayscale value of protein.
Immunofluorescence assay
For immunofluorescence assay, all 5-μm slices were fixed with 4% formaldehyde for 10 min, permeabilized with 0.3% Triton X-100 for 15 min. Then the slices were blocked in goat serum (Solarbio) for 15 min at 37°C and incubated overnight at 4°C with anti-VEGF antibody (1:100; Bioworld, Minneapolis, USA). After being washed with PBS (three times), all the slices were incubated with HRPconjugated goat secondary antibody (1:70; Bioworld). DAPI (Genview, Shanghai, China) was used for counterstaining.
Fluorescence was visualized with a microscope (TCSSP2-AOBS-MP; Leica Microsystems CMS, Munich, Germany) under the magnification of ×40.
PAI-1 transcriptional activity analysis
The 3′UTR segments of the PAI-1 gene were amplified by PCR from the total cDNA of MAECs and inserted into the pMIR-REPORT™ Renilla Luciferase (pMIR-R-L) control vector (Ambion, Austin, USA) using HindIII and SpeI as restriction sites. Target segments and mutant inserts were confirmed by sequencing. Renilla luciferase vector (Ambion) was used for normalization. The cells were cotransfected in 24-well plates using Lipofectamine 2000 (Invitrogen) according to the protocol of the manufacturer with 0.2 μg pMIR-R-L vector and 0.04 μg control vector. Moreover, pCMV6-CLOCK or siRNA-CLOCK (si-1) was used for each well. The luciferase activity was measured consecutively using the dual-luciferase reporter assay system (Promega, Madison, USA) 48 h after transfection.
Identification of the vulnerable atherosclerotic plaques
According to previous study [35] , dimercaptosuccinic acid (DMSA) modified ultra-small super paramagnetic iron oxide (USPIO) was synthesized and used to identify vulnerable atherosclerotic plaques by magnetic resonance imaging (MRI) (Gyroscan Intera 1.5 T; Philips, Eindhoven, Netherlands). All mice underwent pharmacological triggering, and images were taken daily for 3 days after DMSA-USPIO infusion. According to the strength of signals in different sequence images, this method can identify the fibrous cap, lipid nucleus and calcification components of plaque.
Rhythm analysis and statistics
Each experiment was performed at least three times. Chronos-fit 1.06 software was used to evaluate rhythm of gene expression. Biomedical variables were expressed as the mean ± standard error (SE) or median value ± quartile range (M ± QR). Data were analyzed using SPSS ® 14.0 software (SPSS, Chicago, USA). Student's t-test or One-way ANOVA was used to analyze the difference between two groups or more than two groups, the chi-square (χ 2 ) test was used to analyze the difference of the clinical features between ACS patients and the healthy individuals, and P < 0.05 was considered to be statistically significant.
Results
ACS patients showed an elevated level of CLOCK in PBMCs
To study the effects of circadian genes in the pathogenesis of ACS, we performed qPCR to examine the mRNA levels of circadian genes in patients' serum samples collected from 0:00 to 24:00. As shown in Fig. 1A , the mRNA expressions of CLOCK and REV-ERBβ were significantly increased in PBMCs of ACS patients collected every 4 h from 0:00 to 24:00, compared with that in control individuals (P < 0.05). However, the mRNA expressions of RORα, RORγ, REV-ERBα, Bmal 1, Bmal 1α, Per 1, Per 2, Per 3, Cry 1, and Cry 2 genes had no obvious difference between the two groups (all P > 0.05; Fig. 1A ). qPCR and western blot analysis results showed that both the mRNA and protein levels of CLOCK were significantly elevated in PBMCs of ACS patients, when compared with those in control individuals (P < 0.05; Fig. 1B,C) . The expressions of LIF, ICAM-1, ADFP, NF-κB, and PAI-1 were all increased in ACS patients when compared with the control individuals (Fig. 1D) . All these data illustrated that CLOCK was overexpressed in ACS patients' PBMCs, suggesting that CLOCK might play an important role in the progression of ACS.
Decreased expression of CLOCK increases the number of atherosclerotic plaques
To study the function of CLOCK in the formation of atherosclerotic plaques, we performed loss of function experiment using AS mouse model. As shown in Fig. 2 , the mRNA expressions of CLOCK, REV-ERBβ, RORα, RORγ, REV-ERBα, Bmal 1, Bmal 1α, Per 1, Per 2, Per 3, Cry 1, and Cry 2 were all significantly increased in the mice model when compared with that in the sham-operated group. In addition, the protein and mRNA levels of CLOCK showed the same trends as determined by the qPCR and western blotting analysis (Fig. 3A,B) . Similarly, immunohistochemistry also showed that CLOCK protein expression in mouse model was higher than the control group (Fig. 3C) . The model group also showed elevated mRNA levels of LIF, ICAM-1, ADFP, NF-κB, and PAI-1, as revealed by qPCR analysis (Fig. 3D) . Figure 3E showed the efficient knockdown of CLOCK. CLOCK-knockout transgenic mouse was adopted to build the AS model. As shown in Fig. 3F , all the expression levels of LIF, ICAM-1, ADFP, NF-κB, and PAI-1 were downregulated in the CLOCK-knockdown group, compared with that in the model +si-NC group. In addition, the CLOCK-knockdown group had a fewer number of unstable plaques (Fig. 2G) . These data indicated 
Knockdown of CLOCK weakens cell adhesive capacity through directly binding to PAI-1 promoter in MAECs
To explore the underlying mechanism of CLOCK on the progression of ACS, the expressions of genes related to the progression of ACS such as LIF, ICAM-1, ADFP, NF-κB, and PAI-1 were detected. As shown in Fig. 4A , the results from CHIP assay showed that CLOCK protein directly bound to the PAI-1 promoter, indicating that PAI-1 is the target of CLOCK. In addition, CLOCK-overexpressing vector and siRNA targeting to human CLOCK gene were recruited to upregulate and downregulate the expression of CLOCK, respectively, Fig. 4B showed the transfected efficiency of them, and siRNA1 showed the highest knockdown efficiency among the three siRNAs. Then, the effects of CLOCK on the mRNA levels of LIF, ICAM-1, ADFP, NF-κB, and PAI-1 were elevated by qPCR. Results showed that elevation of CLOCK level increased the expression of PAI-1, whereas reduction of CLOCK level decreased the expression of ICAM-1, PAI-1, and NF-κB, significantly, but had no effect on the expression of LIF and ADFP regardless of upregulation or downregulation of CLOCK expression (Fig. 4C) . The luciferase report assay was carried out to explore the function of CLOCK on the transcriptional level of PAI-1. As shown in Fig. 4D , CLOCK positively regulated the expression of PAI-1 in transcriptional level. Additionally, knockdown of CLOCK in MAECs could reduce the number of attachment cells (Fig. 4E) , as well as the expressions of VCAM-1, CCL-2, and CCL-5 (Fig. 4F) . These results revealed that CLOCK intervened with cell adhesive capacity through directly binding to the PAI-1 promoter in MAECs.
Expression of PAI-1 is consistent with CLOCK
To explore the role of PAI-1 in the progression of AS, we performed qPCR to determine the mRNA levels of PAI-1 in PBMCs from ASC patients or the healthy individuals collected every 4 h from 0:00 to 24:00. As shown in Fig. 5A , the mRNA expression of PAI-1 was significantly increased in PBMCs of ACS patients collected from 4:00 to 12:00, compared with that in control individuals (P < 0.05). It has been reported that CLOCK directly regulates PAI-1 expression [36] . The present study also demonstrated that the mRNA expression of PAI-1 was significantly deceased in CLOCK-knockdown atherosclerosis model mice, compared with that in control model mice ( Fig. 5B, P < 0.05) . Additionally, immunofluorescence assay was performed to confirm the protein level of PAI-1 in carotid artery tissues from CLOCK-knockdown AS mouse model or control atherosclerosis mouse model. The results were consistent with that in Fig. 5B , the CLOCK-knockdown atherosclerosis model mice showed a decreased expressed level of PAI-1 (Fig. 5C ). These data indicated that PAI-1 expression was consistent with CLOCK, which might play a vital role in the pathogenesis of ASC.
Decreased expression of CLOCK reduces the formation of atherosclerotic plaques through downregulating PAI-1
To explore the function of CLOCK/PAI-1 in pathogenetic atherosclerosis, overexpressed vector of PAI-1 and siRNA targeting PAI-1 (si-PAI-1) were used to upregulate and downregulate PAI-1 expression in MAECs, respectively. Figure 6A showed the transfection efficiency of vector-PAI-1 and si-PAI-1. Knockdown of CLOCK could reduce the number of adhesive cells, while up-regulation of PAI-1 increased the number of adhesive cells; and PAI-1 up-regulation also weakened the reduction of adhesive cells induced by CLOCK down-regulation The expression levels of VCAM-1, CCL-2, and CCL-5 were detected by qPCR after cells were transfected with siRNA-CLOCK. Data are presented as the mean ± standard error (SE) and represent three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001; ## P < 0.01, ### P < 0.001. (Fig. 6B) . Knockdown of CLOCK could also reduce the number of unstable plaques of the mouse model, and the effect was impaired when PAI-1 was overexpressed (Fig. 6C) . Furthermore, upregulating PAI-1 expression increased the number of adhesive cells and the expressions of VCAM-1, CCL-2, and CCL-5, as well as the number of unstable plaques from the atherosclerosis mouse model (Fig. 6B,  D) , and knockdown of CLOCK could suppress the expression of VCAM-1, CCL-2, and CCL-5 of the atherosclerosis mouse model; however, these effects were impaired when PAI-1 was overexpressed, and vice versa (Fig. 6D) . These results showed that decreased expression of CLOCK improved the stability of atherosclerotic plaques through downregulating PAI-1.
Discussion
Cardiovascular diseases are closely related to circadian rhythm, which is under the control of an internal biological clock mechanism. Although a biological clock exists not only in the hypothalamus but also in each peripheral tissue, the biological relevance of the peripheral clock remains to be elucidated by identifying genes whose expression is regulated by it.
In this study, we showed for the first time the global disruption of gene rhythmicity in ACS patients compared to healthy volunteers. Of the genes examined in this study, we found that only REV-ERBα, RORα, Per 1, and Cry 2 mRNA levels were partially rhythmic in the PBMCs of healthy volunteers, compared with partially rhythmic of RORα, REV-ERBα, Per 3, Cry 1, and Cry 2 mRNA levels in that of ACS patients. While Per 1, Cry 1, and Bmal 1 were demonstrated to be rhythmically expressed in human oral mucosa, and similar rhythms of Per1 and Bmal 1 in human skin [37] . Based on data from these studies and our own study, we hypothesized that circadian genes might have tissue-specific expression patterns. Specific rhythmic change of CLOCK gene expression was shown to play a key role not only in atherosclerosis and its complications [38] , but also in the maintenance of diurnal variation in thrombogenesis [39] . Our study excluded circadian-related diseases, such as diabetes, hyperlipidemia, and cancer, and found that alteration of CLOCK gene rhythm might be the key target of STEMI circadian variation. Further studies are needed to confirm the molecular mechanisms discussed.
CLOCK protein was shown to target the promoter of PAI-1 gene which is a clock-controlled gene expressed in HVECs. Furthermore, a profound increase of PAI-1 expression in ACS patients was found, which was significantly higher particularly at 4:00, 8:00, and 12:00 compared with baseline time point. PAI-1 is the primary physiological inhibitor of plasminogen activators and an independent risk factor for cardiovascular disease, whose activity and levels robustly fluctuate in a circadian manner, and as a consequence, contributing to hypofibrinolysis during the early morning [40] . Plasma PAI-1 concentrations are regulated at the level of gene expression, and the half-life of PAI-1 circulation in the bloodstream is relatively short. Expression of the PAI-1 gene is regulated by several cytokines, hormones and metabolic factors such as TNFα, TGFβ1, insulin, glucocorticoids, angiotensin II, fatty acids, and glucose [41] . Circadian fluctuation of plasma PAI-1 levels is regulated at the gene expression level through direct transactivation by circadian clock proteins that drive the endogenous biological clock [42] . Fundamental circadian clock components may drive circadian variation in PAI-1, which in turn influences the pathogenesis, timing, and treatment of acute atherothrombotic events [43] . The CLOCK: BMAL2 heterodimer has been proved to induce PAI-1 gene expression by binding to two E-box enhancers in the PAI-1 promoter, and furthermore both BMAL1 and BMAL2 are present in PAI-1-expressing tissues, such as heart, liver, kidney, and aortic endothelial and smooth muscle cells [44] . Recently, chronic phase shifts was shown to result in increased plasma PAI-1 level through induction of PAI-1 mRNA expression and down-regulation of tissue-type plasminogen activator mRNA expression in the mice liver, which might induce hypofibrinolysis and increase the risk of cardiovascular Immunofluorescence analysis of protein expression of PAI-1 in CLOCK-knockdown atherosclerosis mice and the control mice. Data are presented as the mean ± SE and represent three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001. AS, atherosclerosis.
events by inducing PAI-1 gene expression in obese individuals [45] . CLOCK and BMAL2 in peripheral tissue may also directly regulate circadian expression of the PAI-1 gene, contributing to the morning onset of acute myocardial infarction [45] .
Atherosclerotic plaque ruptures are widely known to have a close relationship with pathological processes of ACS [46, 47] , suggesting the validity control the formation and rupture is a potent therapeutic method for ACS and other cardiovascular disease. The present study, firstly verified that knockdown of CLOCK could impair the ability of cell adhesion ability, reduce the number of adhesion cells and atherosclerotic plaque, suggesting that CLOCK might involve in the pathological processes of cardiovascular disease via modulating atherosclerotic plaque formation. A previous study revealed that CLOCK, Bmal 1, Per 1, Per 2, and Rev-ERBα were significantly upregulated in night-shift nurses, compared with dayshift nurses [48] . A previous study in Japanese men showed that day and night subversive practitioners are at high risk of cardiovascular events, which is 2.32 times of that in day workers or fixed night workers [49] . Additionally, decreased expression of CLOCK gene in circulatory system affects factors involved in both blood coagulation and fibrinolysis, which was enhanced in mice [50] . These data might imply that CLOCK may participate in the regulation of thrombotic homeostasis through the fibrinolytic system [50] , however, the underlying mechanism needs to be further explored in cardiovascular disease, such as acute myocardial infarction.
Our data demonstrated that CLOCK expression is significantly increased in ACS patients and mouse model. CLOCK gene binds directly to the promoter of PAI-1 and positively regulates its expression. CLOCK gene promotes the formation of unstable atherosclerotic plaque and increases the expressions of VCAM-1, CCL-2, and CCL-5 through upregulating PAI-1 expression. The circadian oscillation of CLOCK expression might contribute to the abnormal circadian variation of atherosclerosis. The present study provides a novel explanation for 'morning peak' phenomenon of acute cardiovascular events, as well as a new target for the improvement of morning peak phenomenon of ACS patients. Furthermore, the circadian rhythmicity, at both the cellular and whole organism level, might promote unbalanced coagulation and fibrinolysis in clinic, which may eventually lead to the occurrence of acute cardiovascular and cerebrovascular events. Elucidation of the biological relevance of the peripheral clock system will provide new insights into the pathological process and novel preventive options for cardiovascular diseases. 
